Search

Author/Creator Wissing, Michel D.

1. CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate‐resistant prostate cancer previously treated with docetaxel. Issue 6 (3rd October 2014)

Authors:
Wissing, Michel D.; Coenen, Jules L.L.M.; van den Berg, Pieter; Westgeest, Hans M.; van den Eertwegh, Alfons J.M.; van Oort, Inge M.; Bos, Monique M.; Bergman, André M.; Hamberg, Paul; ten Tije, Albert J.; Los, Maartje; Lolkema, Martijn P.J.K.; de Wit, Ronald; Gelderblom, Hans
Journal:
International journal of cancer
Issue:
Volume 136:Issue 6(2015:Mar. 15)
Page Start:
E760
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. CA‐125 reduction during neoadjuvant chemotherapy is associated with success of cytoreductive surgery and outcome of patients with advanced high‐grade ovarian cancer. (5th February 2020)

Authors:
Kessous, Roy; Wissing, Michel D.; Piedimonte, Sabrina; Abitbol, Jeremie; Kogan, Liron; Laskov, Ido; Yasmeen, Amber; Salvador, Shannon; Lau, Susie; Gotlieb, Walter H.
Journal:
Acta obstetricia et gynecologica Scandinavica
Issue:
Volume 99:Number 7(2020)
Page Start:
933
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Combining the pan‐aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer. (3rd July 2014)

Authors:
Paller, Channing J.; Wissing, Michel D.; Mendonca, Janet; Sharma, Anup; Kim, Eugene; Kim, Hea‐Soo; Kortenhorst, Madeleine S. Q.; Gerber, Stephanie; Rosen, Marc; Shaikh, Faraz; Zahurak, Marianna L.; Rudek, Michelle A.; Hammers, Hans; Rudin, Charles M.; Carducci, Michael A.; Kachhap, Sushant K.
Journal:
Cancer medicine
Issue:
Volume 3:Number 5(2014:Oct.)
Page Start:
1322
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Development and evaluation of a new non-competitive Luminex immunoassay detecting antibodies against human papillomavirus types 6, 11, 16 and 18. (27th May 2021)

Authors:
Trevisan, Andrea; Wissing, Michel D.; Dagenais, Carole; Forest, Pierre; Ramanakumar, Agnihotram V.; Burchell, Ann N.; Franco, Eduardo L.; Coutlée, François; Couillard, Michel
Journal:
Journal of general virology
Issue:
Volume 102:Number 5(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Liquid biopsy‐based targeted gene screening highlights tumor cell subtypes in patients with advanced prostate cancer. Issue 11 (29th September 2022)

Authors:
Derderian, Seta; Vesval, Quentin; Wissing, Michel D.; Hamel, Lucie; Côté, Nathalie; Vanhuyse, Marie; Ferrario, Cristiano; Bladou, Franck; Aprikian, Armen; Chevalier, Simone
Journal:
Clinical and translational science
Issue:
Volume 15:Issue 11(2022)
Page Start:
2597
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Multiple lines of chemotherapy for patients with high‐grade ovarian cancer: Predictors for response and effect on survival. Issue 9 (7th December 2020)

Authors:
Kessous, Roy; Wissing, Michel D.; Laskov, Ido; Abitbol, Jeremie; Bitharas, Joanna; Agnihotram, Venkata R.; Yasmeen, Amber; Salvador, Shannon; Lau, Susie; Gotlieb, Walter H.
Journal:
International journal of cancer
Issue:
Volume 148:Issue 9(2021)
Page Start:
2304
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Psychosocial adjustment to a prostate cancer diagnosis in a cohort of radical prostatectomy patients in Quebec, Canada. Issue 4 (27th February 2019)

Authors:
Wissing, Michel D.; Chevalier, Simone; O'Flaherty, Ana; McKercher, Ginette; Aprikian, Saro; Saad, Fred; Carmel, Michel; Lacombe, Louis; Hamel, Marc; Aprikian, Armen
Journal:
Psycho-oncology
Issue:
Volume 28:Issue 4(2019)
Page Start:
839
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. SARS-CoV-2 antibodies persist up to 12 months after natural infection in healthy employees working in non-medical contact-intensive professions. (January 2023)

Authors:
Mioch, Dymphie; Vanbrabant, Leonard; Reimerink, Johan; Kuiper, Sandra; Lodder, Esther; van den Bijllaardt, Wouter; Kluytmans, Jan; Wissing, Michel D.; Augustijn, Hans; Bartels, Marit; van Jaarsveld, Cornelia H.M.; Leemans, Manon; van Nierop, Peter; van Riet, Natascha; Raaijmakers, Lieke; Reisiger...
Journal:
International journal of infectious diseases
Issue:
Volume 126(2023)
Page Start:
155
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗